GRONINGEN, The Netherlands and MONTREAL, Nov. 28 /CNW/ - Kiadis B.V, a Dutch early product development company, and Celmed BioSciences Inc., a Canadian clinical product development company, today announce their plans to merge both oncology-focused companies. The combined company will be named Kiadis Pharma B.V. and headquartered in the Netherlands with supporting facilities in the Netherlands and Canada.
